Matrix metalloproteinase levels in the differentiation of parapneumonic pleural effusions

Respiration

Volumn 80, Issue 4, 2010, Pages 285-291

  Oikonomidi, Smaragda ^a   Kostikas, Konstantinos ^a   Kalomenidis, Ioannis ^b   Tsilioni, Irene ^a   Daenas, Christos ^a   Gourgoulianis, Konstantinos I ^a   Kiropoulos, Theodoros S ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Empyema; Fibrosis; Matrix metalloproteinases; Pleural effusion; Pleural infection

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE;

ADULT; AGED; ARTICLE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LUNG CANCER; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PLEURA EMPYEMA; PLEURA FLUID; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; EMPYEMA, PLEURAL; EXTRACELLULAR FLUID; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PLEURAL EFFUSION; PNEUMONIA;

EID: 77956988946     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314586     Document Type: Article

References (37)

1. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, De-Carlo A, Engler JA: Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4: 197-250.
2. Lemaitre V, D'Armiento J: Matrix metalloproteinases in development and disease. Birth Defects Res C Embryo Today 2006; 78: 1-10.
3. Vu TH, Werb Z: Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 2000; 14: 2123-2133.
4. Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-174.
5. Folgueras AR, Pendas AM, Sanchez LM, Lopez-Otin C: Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 2004; 48: 411-424.
6. Cataldo DD, Gueders M, Munaut C, Rocks N, Bartsch P, Foidart JM, Noel A, Louis R: Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases mRNA transcripts in the bronchial secretions of asthmatics. Lab Invest 2004; 84: 418-424.
7. Simpson JL, Scott RJ, Boyle MJ, Gibson PG: Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. Am J Respir Crit Care Med 2005; 172: 559-565.
8. Shapiro SD: Proteinases in chronic obstructive pulmonary disease. Biochem Soc Trans 2002; 30: 98-102.
9. Demedts IK, Brusselle GG, Bracke KR, Vermaelen KY, Pauwels RA: Matrix metalloproteinases in asthma and COPD. Curr Opin Pharmacol 2005; 5: 257-263.
10. Fligiel SE, Standiford T, Fligiel HM, Tashkin D, Strieter RM, Warner RL, Johnson KJ, Varani J: Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury. Hum Pathol 2006; 37: 422-430.
11. Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N: Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab Invest 1998; 78: 687-698.
12. Eickelberg O, Sommerfeld CO, Wyser C, Tamm M, Reichenberger F, Bardin PG, Soler M, Roth M, Perruchoud AP: MMP and TIMP expression pattern in pleural effusions of different origins. Am J Respir Crit Care Med 1997; 156: 1987-1992.
13. Hurewitz AN, Zucker S, Mancuso P, Wu CL, Dimassimo B, Lysik RM, Moutsiakis D: Human pleural effusions are rich in matrix metalloproteinases. Chest 1992; 102: 1808-1814.
14. Iglesias D, Alegre J, Aleman C, Ruiz E, Soriano T, Armadans LI, Segura RM, Angles A, Monasterio J, de Sevilla TF: Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions. Eur Respir J 2005; 25: 104-109.
15. Sheen P, O'Kane CM, Chaudhary K, Tovar M, Santillan C, Sosa J, Caviedes L, Gilman RH, Stamp G, Friedland JS: High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation. Eur Respir J 2009; 33: 134-141.
16. Park KJ, Hwang SC, Sheen SS, Oh YJ, Han JH, Lee KB: Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer. Respiration 2005; 72: 166-175.
17. Zucker S, Mirza H, Conner CE, Lorenz AF, Drews MH, Bahou WF, Jesty J: Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase a activation and cell proliferation. Int J Cancer 1998; 75: 780-786.
18. Jantz MA, Antony VB: Pathophysiology of the pleura. Respiration 2008; 75: 121-133.
19. Davies CW, Kearney SE, Gleeson FV, Davies RJ: Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med 1999; 160: 1682-1687.
20. Koegelenberg CF, Diaconi AH, Bolligeri CT: Parapneumonic pleural effusion and empyema. Respiration 2008; 75: 241-250.
21. Porcel JM, Vives M, Esquerda A: Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions. Chest 2004; 125: 160-164.
22. Jimenez Castro D, Diaz G, Perez-Rodriguez E, Light RW: Prognostic features of residual pleural thickening in parapneumonic pleural effusions. Eur Respir J 2003; 21: 952-955.
23. Light RW: A new classification of parapneumonic effusions and empyema. Chest 1995; 108: 299-301.
24. Kalomenidis I, Bouros D: Pleural fluid pH in parapneumonic pleural effusions: drawing the line. Respiration 2005; 72: 345-346.
25. Porcel JM, Vives M, Esquerda A, Ruiz A: Usefulness of the British Thoracic Society and the American College of Chest Physicians guidelines in predicting pleural drainage of non-purulent parapneumonic effusions. Respir Med 2006; 100: 933-937.
26. Pardo A, Selman M: Matrix metalloproteases in aberrant fibrotic tissue remodeling. Proc Am Thorac Soc 2006; 3: 383-388.
27. Tsilioni I, Gourgoulianis K, Kiropoulos T: Oxidative stress and pleural effusions. Eur Respir J 2008; 32(suppl 52):A21.
28. Papageorgiou E, Kostikas K, Kiropoulos T, Karetsi E, Mpatavanis G, Gourgoulianis KI: Increased oxidative stress in exudative pleural effusions: a new marker for the differentiation between exudates and transudates? Chest 2005; 128: 3291-3297.
29. Davies CW, Gleeson FV, Davies RJ: BTS guidelines for the management of pleural infection. Thorax 2003; 58(suppl 2):ii18-ii28.
30. Pneumatikos I, Bouros D: Pleural effusions in critically ill patients. Respiration 2008; 76: 241-248.
31. Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr: Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77: 507-513.
32. Marshall BC, Santana A, Xu QP, Petersen MJ, Campbell EJ, Hoidal JR, Welgus HG: Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells: cellular differentiation influences expression. J Clin Invest 1993; 91: 1792-1799.
33. Martin J, Yung S, Robson RL, Steadman R, Davies M: Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells. Perit Dial Int 2000; 20: 524-533.
34. Colice GL, Curtis A, Deslauriers J, Heffner J, Light R, Littenberg B, Sahn S, Weinstein RA, Yusen RD: Medical and surgical treatment of parapneumonic effusions: an evidencebased guideline. Chest 2000; 118: 1158-1171.
35. Heffner JE, Brown LK, Barbieri C, DeLeo JM: Pleural fluid chemical analysis in parapneumonic effusions: a meta-analysis. Am J Respir Crit Care Med 1995; 151: 1700-1708.
36. Alegre J, Jufresa J, Segura R, Ferrer A, Armadans L, Aleman C, Marti R, Ruiz E, Fernandez de Sevilla T: Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions. Eur Respir J 2002; 19: 320-325.
37. Porcel JM, Galindo C, Esquerda A, Trujillano J, Ruiz-Gonzalez A, Falguera M, Vives M: Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated nonpurulent from uncomplicated parapneumonic effusions. Respirology 2008; 13: 58-62.